FOXA1 reprograms the TGF-β-stimulated transcriptional program from a metastasis promoter to a tumor suppressor in nasopharyngeal carcinoma
Authors:
- Junjun LiJLJunjun Li
- Shengnan ChenSCShengnan Chen
- Jing CaiJCJing Cai
- Yuanyuan BanYBYuanyuan Ban
- Qian PengQPQian Peng
- Yin ZhouYZYin Zhou
- Zhaoyang ZengZZZhaoyang Zeng
- Xiaoling LiXLXiaoling Li
- Wei XiongWXWei Xiong
- Guiyuan LiGLGuiyuan Li
- 1 February 2019
- journal article
- research article
- Published by Elsevier in Cancer Letters
- Vol. 442, 1-14
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81572667, 81772902, 81872278, 81802945)
- National “111” Project (#111-2-12)
- Natural Science Foundation of Hunan Province, China (2018JJ1040)
- Hunan Provincial Key Research and Development Program (2018SK2130, 2018SK2131)
This publication has 52 references indexed in Scilit:
- Loss of the Urothelial Differentiation Marker FOXA1 Is Associated with High Grade, Late Stage Bladder Cancer and Increased Tumor ProliferationPLOS ONE, 2012
- Critical and Reciprocal Regulation of KLF4 and SLUG in Transforming Growth Factor β-Initiated Prostate Cancer Epithelial-Mesenchymal TransitionMolecular and Cellular Biology, 2012
- Differential expression in RNA-seq: A matter of depthGenome Research, 2011
- Foxa1 Functions as a Pioneer Transcription Factor at Transposable Elements to Activate Afp during Differentiation of Embryonic Stem CellsJournal of Biological Chemistry, 2010
- Loss of FOXA1/2 Is Essential for the Epithelial-to-Mesenchymal Transition in Pancreatic CancerCancer Research, 2010
- Systematic and integrative analysis of large gene lists using DAVID bioinformatics resourcesNature Protocols, 2008
- SMAD3 prevents binding of NKX2.1 and FOXA1 to the SpB promoter through its MH1 and MH2 domainsNucleic Acids Research, 2007
- Repression by Groucho/TLE/Grg Proteins: Genomic Site Recruitment Generates Compacted Chromatin In Vitro and Impairs Activator Binding In VivoMolecular Cell, 2007
- Development of TGF-β signalling inhibitors for cancer therapyNature Reviews Drug Discovery, 2004
- High level expression of ΔN-p63: a mechanism for the inactivation of p53 in undifferentiated nasopharyngeal carcinoma (NPC)?Oncogene, 2000